cjc-1295 ipamorelin recovery improvement + — Peptide Therapy Online CJC-1295 + Ipamorelin: Benefits, Differences,
Description
Zhao Y, Marotta M, Eichler EE, Eng C, Tanaka H
Among those, IGF-I has been reported to be a potent candidate due to its para/autocrine functions
A critical distinction emerges: equivalent anabolic effects may be achievable with lower IGF-1 LR3 doses than HGH doses, reflecting the direct versus indirect mechanism difference
Skeletal muscles with sufficient endurance for exercise may not be as effective as expected
PMID 10736352
